甘李药业签订不低于30亿元供应框架协议

Core Viewpoint - Gannee Pharmaceutical (603087.SH) has signed a Technical Transfer and Supply Agreement with Funda o Oswaldo Cruz-Bio-Manguinhos (FZ) and BIOMM S.A. for a partnership project in Brazil, which is expected to positively impact the company's financial performance in 2025 and beyond [1] Group 1 - The company has entered into a Technical Transfer and Supply Agreement involving the transfer of insulin glargine technology and the supply of active pharmaceutical ingredients and injection solutions [1] - A Supply Framework Agreement has also been signed with BIOMM, with a total contract value expected to be no less than RMB 3 billion (including tax), subject to actual order amounts [1] - Both agreements are part of the company's routine business operations and align with its strategic development direction, potentially enhancing overall profitability [1]